Serious Risks and Warnings
While a tummy ache is manageable, there are more severe risks associated with semaglutide. When asking if Wegovy is safe, you must consider these rare but serious warnings.
1. Thyroid C-Cell Tumours (Boxed Warning)
Wegovy carries a "Boxed Warning," the FDA's strictest warning. In studies involving rodents, semaglutide caused thyroid C-cell tumours, including Medullary Thyroid Carcinoma (MTC).
- The Reality: It is not yet known if Wegovy causes these tumours in humans, as human studies have not confirmed this link. However, the risk is significant enough to warrant a specific contraindication (see below).
2. Acute Pancreatitis
Inflammation of the pancreas (pancreatitis) has been reported in clinical trials. This is a painful and potentially dangerous condition. If you experience severe pain in your stomach area that will not go away, with or without vomiting, and the pain radiates to your back, stop the medication immediately and seek help.
3. Gallbladder Problems
Rapid weight loss is a known trigger for gallbladder issues, but Wegovy itself may increase the risk. This can include gallstones (cholelithiasis) and gallbladder inflammation. Some patients may require surgery to remove the gallbladder.
4. Kidney Injury
Because Wegovy causes nausea, vomiting, and diarrhoea, there is a risk of severe dehydration. If left untreated, dehydration can lead to acute kidney injury or worsening of chronic kidney failure. Drinking plenty of fluids is essential while on this medication.
5. Increased Heart Rate
Wegovy can increase your resting heart rate. Patients should have their heart rate monitored regularly. If you feel your heart racing or pounding in your chest for several minutes, consult your doctor.
6. Suicidal Thoughts or Behaviour
Although rare, there have been reports of suicidal ideation with weight management drugs. Patients should monitor their mood and behaviour. If you notice depression, anxiety, or mood changes, stop the drug and contact a healthcare provider.